<?xml version='1.0' encoding='utf-8'?>
<document id="26011058"><sentence text="Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently."><entity charOffset="0-9" id="DDI-PubMed.26011058.s1.e0" text="Sunitinib" /><entity charOffset="10-19" id="DDI-PubMed.26011058.s1.e1" text="ibuprofen" /><entity charOffset="93-102" id="DDI-PubMed.26011058.s1.e2" text="sunitinib" /><pair ddi="false" e1="DDI-PubMed.26011058.s1.e0" e2="DDI-PubMed.26011058.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26011058.s1.e0" e2="DDI-PubMed.26011058.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26011058.s1.e0" e2="DDI-PubMed.26011058.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26011058.s1.e1" e2="DDI-PubMed.26011058.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26011058.s1.e1" e2="DDI-PubMed.26011058.s1.e2" /></sentence><sentence text="Tyrosine kinase inhibitor sunitinib (used in GIST, advanced RCC, and pancreatic neuroendocrine tumors) undergoes CYP3A4 metabolism and is an ABCB1B and ABCG2 efflux transporters substrate"><entity charOffset="0-8" id="DDI-PubMed.26011058.s2.e0" text="Tyrosine" /><entity charOffset="26-35" id="DDI-PubMed.26011058.s2.e1" text="sunitinib" /><pair ddi="false" e1="DDI-PubMed.26011058.s2.e0" e2="DDI-PubMed.26011058.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26011058.s2.e0" e2="DDI-PubMed.26011058.s2.e1" /></sentence><sentence text=" We assessed the pharmacokinetic interaction with ibuprofen (an NSAID used by patients with cancer) in Balb/c male and female mice"><entity charOffset="50-59" id="DDI-PubMed.26011058.s3.e0" text="ibuprofen" /></sentence><sentence text=" Mice (study group) were coadministered (30 min apart) 30 mg/kg of ibuprofen and 60 mg/kg of sunitinib PO and compared with the control groups, which received sunitinib alone (60 mg/kg, PO)"><entity charOffset="67-76" id="DDI-PubMed.26011058.s4.e0" text="ibuprofen" /><entity charOffset="93-105" id="DDI-PubMed.26011058.s4.e1" text="sunitinib PO" /><entity charOffset="159-168" id="DDI-PubMed.26011058.s4.e2" text="sunitinib" /><pair ddi="false" e1="DDI-PubMed.26011058.s4.e0" e2="DDI-PubMed.26011058.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26011058.s4.e0" e2="DDI-PubMed.26011058.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26011058.s4.e0" e2="DDI-PubMed.26011058.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26011058.s4.e1" e2="DDI-PubMed.26011058.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26011058.s4.e1" e2="DDI-PubMed.26011058.s4.e2" /></sentence><sentence text=" Sunitinib concentration in plasma, brain, kidney, and liver was measured by HPLC as scheduled and noncompartmental pharmacokinetic parameters estimated"><entity charOffset="1-10" id="DDI-PubMed.26011058.s5.e0" text="Sunitinib" /></sentence><sentence text=" In female control mice, sunitinib AUC0→∞ decreased in plasma (P &lt; 0"><entity charOffset="25-41" id="DDI-PubMed.26011058.s6.e0" text="sunitinib AUC0→∞" /></sentence><sentence text="05), was higher in liver and brain (P &lt; 0" /><sentence text="001), and lower in kidney (P &lt; 0" /><sentence text="001) vs" /><sentence text=" male control mice" /><sentence text=" After ibuprofen coadministration, female mice showed lower AUC0→∞ in plasma (P &lt; 0"><entity charOffset="7-16" id="DDI-PubMed.26011058.s11.e0" text="ibuprofen" /></sentence><sentence text="01), brain, liver, and kidney (all P &lt; 0" /><sentence text="001)" /><sentence text=" However, in male mice, AUC0→∞ remained unchanged in plasma, increased in liver and kidney, and decreased in brain (all P &lt; 0" /><sentence text="001)" /><sentence text=" The tissue-to-plasma AUC0→∞ ratio was similar between male and female control mice, but changed after ibuprofen coadministration: Male mice showed 1"><entity charOffset="103-112" id="DDI-PubMed.26011058.s16.e0" text="ibuprofen" /></sentence><sentence text="6-fold higher liver-to-plasma ratio (P &lt; 0" /><sentence text="001) while remained unchanged in female mice and in kidney (male and female mice) but decreased 55% in brain (P &lt; 0" /><sentence text="05)" /><sentence text=" The tissue-to-plasma partial AUC ratio, the drug tissue targeting index, and the tissue-plasma hysteresis-like plots also showed sex-based ibuprofen-sunitinib drug interaction differences" /><sentence text=" The results illustrate the relevance of this DDI on sunitinib pharmacokinetics and tissue uptake"><entity charOffset="53-62" id="DDI-PubMed.26011058.s21.e0" text="sunitinib" /></sentence><sentence text=" These may be due to gender-based P450 and efflux/transporters differences" /><sentence text="" /></document>